我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

冠心病糖代谢异常患者血浆Ghrelin水平及临床意义

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第4期
页码:
468-470，479
栏目:
临床研究
出版日期:
2012-08-25

文章信息/Info

Title:
Plasma ghrelin level in patients with coronary heart disease with abnormal glucose metabolism and its clinical significance
作者:
庞军刚; 徐 新; 唐良秋; 张社兵; 江志平
(粤北人民医院心血管内科，广东 韶关 512026)
Author(s):
PANG Jun-gang;  XU Xin;  TANG Liang-qiu;  ZHANG She-bing;  JIANG Zhi-ping
(Department of Cardiology, Yuebei People’s Hospital, Yuebei 512026, Guangdong, China)
关键词:
冠状动脉疾病; 糖代谢异常; 胃饥饿素
Keywords:
coronary disease;  abnormal glucose metabolism;  ghrelin
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:探讨冠心病糖代谢异常患者血浆胃饥饿素（Ghrelin）水平及其相关临床意义。方法： 将纳入研究对象依据相关检验及检查结果分为正常对照组、冠心病组（冠心病糖代谢正常组和冠心病糖代谢异常组）、单纯糖代谢异常组。收集所有入选对象入院第2天清晨空腹血样，采用ELISA方法同批检测血浆Ghrelin水平。结果： ①冠心病组及单纯糖代谢异常组血浆Ghrelin水平均显著低于正常对照组。②冠心病糖代谢异常组血浆Ghrelin水平显著低于冠心病糖代谢正常组及单纯糖代谢异常组。③析因分析结果显示：冠心病与糖代谢异常在对血浆Ghrelin水平影响方面不存在交互作用。然而，糖代谢异常比冠心病对血浆Ghrelin水平的影响更明显。结论： 冠心病糖代谢异常患者血浆Ghrelin水平显著下降，且糖代谢异常对Ghrelin的影响更明显。
Abstract:
AIM:To study plasma ghrelin level distribution in patients with coronary heart disease (CHD) with abnormal glucose metabolism and to discuss its clinical significance. METHODS: According to laboratory examination results, subjects were divided into control group, coronary heart disease with normal glucose metabolism group, coronary heart disease with abnormal glucose metabolism group and abnormal glucose metabolism group. Fasting blood samples were collected the morning after admission with EDTA-2K anticoagulation tubes. Blood samples were then transferred to centrifuge tubes containing aprotinin and were centrifuged to extract plasma for cryopreservation. All blood plasma ghrelin levels were tested with ELISA. RESULTS: Compared with those in control group, ghrelin levels were significantly reduced in the group with CHD with normal glucose metabolism, group of CHD with abnormal glucose metabolism and group with abnormal glucose metabolism. Compared with those in the group of CHD with normal glucose metabolism, levels of ghrelin were significantly reduced in patients with CHD with abnormal glucose metabolism. Using CHD and abnormal glucose metabolism as two factors affecting plasma ghrelin levels, factorial analysis showed no interaction (P=0.453). However, the group of abnormal glucose metabolism had more effect on plasma ghrelin levels than CHD. CONCLUSION: Ghrelin levels decreased significantly in patients with CHD with abnormal glucose metabolism and abnormal glucose metabolism has more obvious effects on ghrelin levels.

参考文献/References

[1]Kojima M,Hosoda H,Date Y,et al.Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J].Nature,1999,402(6762):656-660.

[2]De Vriese C,Delporte C.Ghrelin:A new peptide regulaiting growth hormone release and food intake[J].Int J Biochem Cell Biol,2008,40(8):1420-1424.

[3]Iglesias MJ,Pi eiro R,Blanco M,et al.Growth hormone releasing peptide(ghrelin)is synthesized and secreted by cardiomyocytes[J].J Cardiovasc Res,2004,62(3):481-488.

[4]Gnanapavan S,Kola B, Bustin SA,et al.The tissuse distribution of the mRNA of ghrelin and subtypers of its receptor,GHS-R, in humans[J].J Clin Endocrinol Metab,2002,87(6):2988-2991.

[5]American Diabetes Association.Standards of medical care in diabetes-2009[J].Diabetes Care, 2009,(Suppl 1):S13-S61.

[6]Soeki T,Kishimoto I,Schwenke DO,et al.Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction[J].Am J Physiol Heart Circ Physiol,2008,294(1):H426-H432.

[7]Schwenke DO, Tokudome T,Kishimoto I,et al.Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality[J].Endocrinology,2008,149(10):5172-5176.

[8]P ykk SM,Kellokoski E,H rkk S,et al.Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes[J].J Diabetes,2003,52(10):2546-2553.

[9]Kola B,Hubina E,Tucci SA,et al.Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase[J].J Biol Chem,2005, 280(26):25196-25201.

[10]Russell 3rd RR,Li J,Coven DL,et al.AMP-activated protein kiase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis,and injury[J].J Clin Invest,2004,114(4):495-503.

[11]Terai K,Hiramoto Y,Masaki M,et al.AMP-acttivated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress[J].Mol Cell Bol,2005,25(21):9554-9575.

[12]Anderwald C,Brabant G,Bernroider E,et al.Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients[J].J Diabetes,2003,52(7):1792-1798.

[13]Murdolo G, Lucidi P,Di Loreto C,et al.Insulin is required for prandial ghrelin suppression in humans[J]. Diabetes,2003,52(12):2923-2927.

[14]McLaughlin T,Abbasi F,Lamendola C,et al.Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls[J].Clin Endocrinol Metab,2004,89(4):1630-1635.

备注/Memo

备注/Memo:
收稿日期：2011-11-28.通讯作者：徐新，教授，主要从事心脏介入治疗和起搏器安装及调试研究 Email：03xuexin@163.com 作者简介：庞军刚，住院医师，硕士生Email：pangjg2008@hotmail.com
更新日期/Last Update: 2012-07-20